题名

The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?

DOI

10.1016/j.jtcme.2020.05.003

作者

Andréa D. Fuzimoto；Ciro Isidoro

关键词

Coronavirus ； COVID-19 ； Herbs ； Natural compounds ； Antiviral ； Pandemic

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

10卷4期（2020 / 07 / 01）

页次

405 - 419

内容语文

英文
中文摘要

Introduction: As of March 11th, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. Articles published after the SARS-CoV-1 (2002) epidemic suggest that the use of an herbal-drug integrative medical approach could have contributed to a lower fatality rate and a more rapid response in controlling the outbreak. Methods: Pubmed was searched for articles that investigated the antiviral properties and mechanisms of action of herbs or natural compounds against the SARS-coronavirus (CoV). Results: Forty-three (43) relevant papers were located. A general count rendered 450þ herbs and natural compounds with antiviral properties against the SARS-CoV and related viruses. From the 43 articles, thirty-one (31) uncovered the mechanisms of action of the natural substances able to oppose the coronavirus. Discussion: A series of herbs and natural compounds demonstrated moderate to strong antiviral activity. Research on many herbs-natural compounds also showed potent and significant inhibition of CoV-host protein pathways responsible for different phases of viral replication specifically targeting 3CL^(PRO), PL^(PRO), RdRp, helicase protein, S protein, N protein, 3a protein, Cathepsin L, Nsp1, Nsp3c, and ORF7a, and the S protein/ACE-2 interaction. Conclusion: The herbs-natural compounds with antiviral activity and that caused inhibition/blockade of the CoV-host protein pathways are potential therapeutic candidates. The homology between the SARS-CoV- 1 and SARS-CoV-2 is around 80%. Thus, effective herbs-compounds for the former would likely be beneficial for the latter also depending on target protein similarities between the viruses. Here we provide the mechanistic bases supporting an integrative approach that includes natural compounds to fight coronavirus infections.
主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Wen, C,Shyur, L,Jan, J(2011).Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication.J Tradit Complement Med,1(1),41-50.
    連結：
  2. Coronavirus Disease 2019 (COVID-19) Situation Report - 85. Retrieved on Aprill 14. World Health Organization (WHO); 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200414-sitrep-85-covid-19.pdf?sfvrsn=7b8629bb_4
  3. Naming the Coronavirus Disease (COVID-19) and the Virus that Causes it. Retrieved on April 14th. World Health Organization (WHO); 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-thatcauses-it
  4. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003; 2020. https://www.who.int/csr/sars/country/table2003_09_23/en/
  5. Abd-Elazem, I,Chen, H,Bates, R,Huang, R(2002).Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza.Antivir Res,55(1),91-106.
  6. Auyeung, T,Lee, J,Lai, W(2005).The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study.J Infect,51(2),98-102.
  7. Báez-Santos, Y,St, John, S,Mesecar, A(2015).The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.Antivir Res,115,21-38.
  8. Chan, K,Wong, V,Tang, S(2020).COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-western medicine for the management of 2019 novel coronavirus disease.Am J Chin Med.,48(3),1-26.
  9. Chang, F,Yen, C,Ei-Shazly, M,Lin, W,Lin, K,Wu, Y(2012).Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia.Nat Prod Commun,7(11),1415-1417.
  10. Chen, C,Lin, C,Huang, K(2005).Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3’-digallate (TF3).Evid Based Complement Altern Med,2(2),209-215.
  11. Chen, C,Michaelis, M,Hsu, H(2008).Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication.J Ethnopharmacol,120(1),108-111.
  12. Chen, F,Chan, K,Jiang, Y(2004).In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.J Clin Virol,31(1),69-75.
  13. Chen, L,Li, J,Luo, C(2006).Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features.Bioorg Med Chem,14(24),8295-8306.
  14. Chen, L,Wang, Y,Lin, Y(2005).Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.Bioorg Med Chem Lett,15(12),3058-3062.
  15. Chen, Y,Guo, J,Healy, D,Zhan, S(2007).Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: a meta-analysis.Pharm Pr Granada,5(1),1-9.
  16. Chen, Z,Nakamura, T(2004).Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS.Phytother Res
  17. Chiow, K,Phoon, M,Putti, T,Tan, B,Chow, V(2016).Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection.Asian Pac J Tro Med,9(1),1-7.
  18. Cho, J,Curtis-Long, M,Lee, K(2013).Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa.Bioorg Med Chem,21(11),3051-3057.
  19. Chowdhury, P,Sahuc, M,Rouillé, Y(2018).Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.PloS One,13(11),e0198226.
  20. Cinatl, J,Morgenstern, B,Bauer, G,Chandra, P,Rabenau, H,Doerr, H(2003).Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.Lancet,361(9374),2045-2046.
  21. Cvetkovic, R,Goa, K.(2003).Lopinavir/ritonavir: a review of its use in the management of HIV infection.Drugs,63(8),769-802.
  22. Dai, J,Wang, Q,Su, Y(2017).Emodin inhibition of influenza A virus replication and influenza viral pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB pathways.Molecules,22(10)
  23. Dai, Y,Chen, S,Chai, L,Zhao, J,Wang, Y,Wang, Y(2019).Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide.Crit Rev Food Sci Nutr,59(sup1),S17-S29.
  24. de Wit, E,van Doremalen, N,Falzarano, D,Munster, V(2016).SARS and MERS: recent insights into emerging coronaviruses.Nat Rev Microbiol,14(8),523-534.
  25. Ding, Y,Chen, L,Wu, W,Yang, J,Yang, Z,Liu, S(2017).Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-κB and JAK-STAT signaling pathway.Microb Infect,19(12),605-615.
  26. Efferth, T(2017).From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy.Semin Canc Biol.,46,65-83.
  27. Efferth, T,Romero, M,Wolf, D,Stamminger, T,Marin, J,Marschall, M(2008).The antiviral activities of artemisinin and artesunate.Clin Infect Dis.,47(6),804-811.
  28. Fehr, A,Perlman, S(2015).Coronaviruses: an overview of their replication and pathogenesis.Methods Mol Biol,1282,1-23.
  29. Han, S,Xu, J,Guo, X,Huang, M(2018).Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production.Clin Exp Pharmacol Physiol,45(1),84-93.
  30. Han, Y,Geng, H,Feng, W(2003).A follow-up study of 69 discharged SARS patients.J Tradit Chin Med.,23(3),214-217.
  31. Ho, T,Wu, S,Chen, J,Hsiang, C(2007).Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.Antivir Res,74(2),92-101.
  32. Hoever, G,Baltina, L,Michaelis, M(2005).Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.J Med Chem.,48(4),1256-1259.
  33. Hsu, C,Huwang, K,Chao, C(2006).The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients.Am J Chin Med.,34(6),927-935.
  34. Hsu, C,Hwang, K,Chao, C(2008).An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: a randomized, double-blind, and controlled pilot study.Evid Based Complement Altern Med,5(3),355-362.
  35. Irurzun, A,Carrasco, L(2001).Entry of poliovirus into cells is blocked by valinomycin and concanamycin A.Biochemistry,40(12),3589-3600.
  36. Ivanov, K,Thiel, V,Dobbe, J,Van Der Meer, Y,Snijder, E,Ziebuhr, J(2004).Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase.J Virol,78(11),5619-5632.
  37. Iwata-Yoshikawa, N,Okamura, T,Shimizu, Y,Hasegawa, H,Takeda, M,Nagata, N(2019).TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection.J Virol,93(6),e01815.
  38. Jia, W,Gao, W(2003).Is traditional Chinese medicine useful in the treatment of SARS?.Phytother Res,17(7),840-841.
  39. Jiang, Y,Wnag, R,Liu, J(2004).Effect of integrative Chinese and western medicine on T-lymphocyte subsets in treating patients with severe acute respiratory syndrome.Zhongguo Zhong Xi Yi Jie He Za Zhi.,24(6),514-516.
  40. Jie, C,Luo, Z,Chen, H(2017).Indirubin, a bisindole alkaloid from Isatis indigotica, reduces H1N1 susceptibility in stressed mice by regulating MAVS signaling.Oncotarget,8(62),105615-105629.
  41. Kao, J,Fu, W,Tsai, T(2018).The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR.PLoS Neglected Trop Dis,21(8),e0006715.
  42. Khan, S,Zia, K,Ashraf, S,Uddin, R,Ul-Haq, Z(2021).Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.J Biomol Struct Dyn,39(7)
  43. Kim, D,Min, J,Jang, M(2019).Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells.Biomolecules,9(11),696.
  44. Kim, D,Min, J,Jang, M(2019).Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharan-thine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells.Biomolecules,9(11)
  45. Kim, H,Eo, E,Park, H(2010).Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbae radix and Torilis fructus inhibit coronavirus replication in vitro.Antivir Ther,15(5),697-709.
  46. Kim, H,Shin, H,Park, H(2008).In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex.J Clin Virol,41(2),122-128.
  47. Ko, W,Rolain, J,Lee, N(2020).Arguments in favor of remdesivir for treating SARS-CoV-2 infections.Int J Antimicrob Agents,5
  48. Koren, G,King, S,Knowles, S,Phillips, E(2003).Ribavirin in the treatment of SARS: a new trick for an old drug?.Can Med Assoc J,168(1),1289-1292.
  49. Kuba, K,Imai, Y,Rao, S(2005).A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.Nat Med,11(8),875-879.
  50. Lau, K,Lee, K,Koon, C(2008).Immunomodulatory and anti-SARS activities of Houttuynia cordata.J Ethnopharmacol,118(1),79-85.
  51. Lau, T,Leung, P,Wong, E(2005).Using herbal medicine as a means of prevention experience during the SARS crisis.Am J Chin Med.,33(3),345-356.
  52. Leung, P(2007).The efficacy of Chinese medicine for SARS: a review of Chinese publications after the crisis.Am J Chin Med.,35(4),575-581.
  53. Li, G,Fan, Y,Lai, Y(2020).Coronavirus infections and immune responses.J Med Virol,92(4),424-432.
  54. Li, H,Wang, Y,Xu, J,Cao, B(2020).Potential antiviral therapeutics for 2019 novel coronavirus.Zhonghua Jie He He Hu Xi Za Zhi,3
  55. Li, J,Li, S,Du, N.(2004).Clinical study on treatment of severe acute respiratory syndrome with integrative Chinese and Western medicine approach.Zhongguo Zhong Xi Yi Jie He Za Zhi.,24(1),28-31.
  56. Li, J,Zhou, B,Li, C(2015).Lariciresinol-4-O-β-D-glucopyranoside from the root of Isatis indigotica inhibits influenza A virus-induced pro-inflammatory response.J Ethnopharmacol,174,379-386.
  57. Li, S,Chen, C,Zhang, H(2005).Identification of natural compounds with antiviral activities against SARS-associated coronavirus.Antivir Res,67(1),18-23.
  58. Lin, C,Tsai, F,Tsai, C(2005).Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds.Antivir Res,68(1),36-42.
  59. Lin, L,Han, Y,Yang, Z(2003).Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine.Zhongguo Zhong Xi Yi Jie He Za Zhi,23(6),4009-4013.
  60. Liu, B,Zhou, J(2005).SARS-CoV protease inhibitors design using virtual screening method from natural products libraries.J Comput Chem,26(5),484-490.
  61. Liu, J,Manheimer, E,Gluud, C(2004).Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis.J Alternative Compl Med,10(6),1041-1051.
  62. Liu, S,Lu, H,Zhao, Q(2005).Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.Biochim Biophys Acta,1723(1-3),270-281.
  63. Liu, W,Zhu, H,Niu, G(2014).Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors.Bioorg Med Chem,22(1),292-302.
  64. Liu, X,Zhang, M,He, L,Li, Y(2012).Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS).Cochrane Database Syst Rev.,10,CD004882.
  65. Lu, R,Zhao, X,Li, J(2020).Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet,395(10224),565-574.
  66. Lu, W,Zheng, B,Xu, K(2006).Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release.Proc Natl Acad Sci USA.,103(33),12540-12545.
  67. Luo, H,Tang, Q,Shang, Y(2020).Can Chinese medicine Be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs.Chin J Integr Med,26,243-250.
  68. Luo, Z,Liu, L,Wang, X(2019).Epigoitrin, an alkaloid from Isatis indigotica, reduces H1N1 infection in stress-induced susceptible model in vivo and in vitro.Front Pharmacol,10(78)
  69. McBride, R,van Zyl, M,Fielding, B(2014).The coronavirus nucleocapsid is a multifunctional protein.Viruses,6(8),2991-3018.
  70. Millet, J,Whittaker, G.(2015).Host cell proteases: critical determinants of coronavirus tropism and pathogenesis.Virus Res,202,120-134.
  71. Nukoolkarn, V,Lee, V,Malaisree, M,Aruksakulwong, O,Hannongbua, S(2008).Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors.J Theor Biol.,254(4),861-867.
  72. Park, J,Kim, J,Kim, Y(2012).Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.Bioorg Med Chem,20(19),5928-5935.
  73. Park, J,Kim, J,Kwon, J(2013).Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.Bioorg Med Chem,21(13),3730-3737.
  74. Park, J,Ko, J,Kim, D(2016).Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV.J Enzym Inhib Med Chem,31(1),23-30.
  75. Park, J,Yuk, H,Ryu, H(2017).Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors.J Enzym Inhib Med Chem,32(1),504-515.
  76. Perng, Y,Lenschow, D(2018).ISG15 in antiviral immunity and beyond.Nat Reriew Microbiol,16,423-439.
  77. Pons, M(1973).The inhibition of influenza virus RNA synthesis by actinomycin D and cycloheximide.Virology,51(1),120-128.
  78. Ryu, Y,Jeong, H,Kim, J(2010).Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.Bioorg Med Chem,18(22),7040-7047.
  79. Ryu, Y,Park, S,Kim, Y(2010).SARS-CoV 3CLpro inhibitory effects of quinonemethide triterpenes from Tripterygium regelii.Bioorg Med Chem Lett,20(6),1873-1876.
  80. Schwarz, S,Sauter, D,Wang, K(2014).Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus.Planta Med.,80(2-3),177-182.
  81. Schwarz, S,Wang, K,Yu, W,Sun, B,Schwarz, W(2011).Emodin inhibits current through SARS-associated coronavirus 3a protein.Antivir Res,90(1),64-69.
  82. Seong, R,Kim, J,Shin, O(2018).Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways.Acta Virol,62(1),78-85.
  83. Shadrick, W,Ndjomou, J,Kolli, R,Mukherjee, S,Hanson, A,Frick, D(2013).Discovering new medicines targeting helicases: challenges and recent progress.J Biomol Screen,18(7),761-781.
  84. Shen, L,Niu, J,Wang, C(2019).High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses.J Virol,93(12)
  85. Simmons, G,Gosalia, D,Rennekamp, A,Reeves, J,Diamond, S,Bates, P(2005).Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.Proc Natl Acad Sci USA.,102(33),11876-11881.
  86. Smith T, Prosser T. COVID-19 drug therapy - potential options. In: Clinical Drug Information, Clinical Solutions, Elsevier. Retrieved on Mar 16, 2020.. 2020.
  87. Song, Y,Kim, D,Curtis-Long, M(2014).Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits.Biol Pharm Bull,37(6),1021-1028.
  88. Stockman, L,Bellamy, R,Garner, P(2006).SARS: systematic review of treatment effects.PLoS Med,3(9),e343.
  89. Tao, Z,Gao, J,Zhang, G(2014).Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-kB pathway.Biosci Trends,8(1),45-51.
  90. Tong, X,Li, A,Zhang, Z(2004).TCM treatment of infectious atypical pneumonia - a report of 16 cases.J Tradit Chin Med.,24(4),266-269.
  91. Tsai, Y,Lee, C,Yen, H(2020).Antiviral action of tryptanthrin isolated from strobilanthes cusia leaf against human coronavirus NL63.Biomolecules,10(3),366.
  92. Tu, Y(2016).Artemisinin-A gift from traditional Chinese medicine to the World (nobel lecture).Angew Chem Int Ed Engl,55(35),10210-10226.
  93. Venkataraman, S,Prasad, B,Selvarajan, R(2018).RNA dependent RNA polymerases: insights from structure, function and evolution.Viruses
  94. Wang, S,Du, Q,Zhao, K,Li, A,Wei, D,Chou, K(2007).Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy.Amino Acids.,33(1),129-135.
  95. Wang, Z,Chen, X,Chen, F,Zhang, W(2020).Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.Biosci Trends.,14(1),64-68.
  96. Wen, C,Kuo, Y,Jan, J(2007).Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.J Med Chem,50(17),4087-4095.
  97. Weng, J,Lin, C,Lai, H(2019).Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63.Virus Res,273,197767.
  98. Wu, C,Jan, J,Ma, S(2004).Small molecules targeting severe acute respiratory syndrome human coronavirus.Proc Natl Acad Sci USA.,101(27),10012-10017.
  99. Wu, C,Liu, Y,Yang, Y(2020).Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.Acta Phamaceutica Sin B,10(5)
  100. Yan, Y,Fu, Y,Wu, S(2018).Anti-influenza activity of berberine improves prognosis by reducing viral replication in mice.Phytother Res,32(12),2560-2567.
  101. Yang, Y,Islam, M,Wang, J,Li, Y,Chen, X(2020).Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective.Int J Biol Sci.,16(10),1708-1717.
  102. Yang, Z,Wang, Y,Zhong, S(2012).In vitro inhibition of influenza virus infection by a crude extract from Isatis indigotica root resulting in the prevention of viral attachment.Mol Med Rep.,5(3),793-799.
  103. Ye, G,Pan, Z,Pan, Y(2020).Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.J Infect,80(5),e14-e17.
  104. Yi, L,Li, Z,Yuan, K(2004).Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells.J Virol,78(20),11334-11339.
  105. Yin, J,Li, G,Yang, Q,Ren, X(2011).In vitro and in vivo effects of Houttuynia cordata on infectious bronchitis virus.Avian Pathol,40(5),491-498.
  106. Yu, M,Lee, J,Lee, J(2012).Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.Bioorg Med Chem Lett,22(12),4049-4054.
  107. Zeng, R,Yang, R,Shi, M(2004).Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients.J Mol Biol.,341(1),271-279.
  108. Zhang, D,Wu, K,Zhang, X,Deng, S,Peng, B(2020).In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus.J Integr Med.,18(2),152-158.
  109. Zhang, M,Liu, X,He, L(2004).Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence.World J Gastroenterol,10(23),3500-3505.
  110. Zhang, R,Jiao, Q,Wang, B(2003).Controlled clinical study on 49 patients of SARS treated by integrative Chinese and Western medicine.Zhongguo Zhong Xi Yi Jie He Za Zhi,23(9),654-657.
  111. Zhi, H,Zhu, H,Zhang, Y,Lu, Y,Li, H,Chen, D(2019).In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza A virus.Phytomedicine,57,105-116.
  112. Zhou, L,Liu, Y,Zhang, W(2006).Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.J Med Chem,49(12),3440-3443.
  113. Zhu, H,Lu, X,Ling, L(2018).Houttuynia cordata polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection.J Ethnopharmacol,218,90-99.
  114. Zhuang, M,Jiang, H,Suzuki, Y(2009).Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection.Antivir Res,82(1),73-81.
被引用次数
  1. Sameh S. Elhady,Khaled M. Darwish,Ahmed Ashour,Ahmed A. Zaki,Ahmed A. Al-Karmalawy(2022).Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies.Journal of Traditional and Complementary Medicine,12(1),16-34.
  2. Tewin Tencomnao,Siriporn Chuchawankul,Panthakarn Rangsinth,Chanin Sillapachaiyaporn,Atsadang Theerasri,Anchalee Prasansuklab(2021).Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.Journal of Traditional and Complementary Medicine,11(2),144-157.
print cancel